Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROBI: Relief of Bleeding on the Implant
NCT01963403Phase 4Terminated
- Sponsor
- University of California, Davis
- Start
- Dec 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in abnormal uterine bleeding (AUB) comparing EE 30mcg/LNG 150mcg with Placebo (2 arms). Primary endpoint: Number of Participants With Bleeding Improvement at 28 days. Started Dec 2013; status: terminated.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT01963403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01963403.